|
Adverse event preferred term
|
AL n(%) n = 314
|
MAS n(%) n = 105
|
|---|
|
Pyrexia
|
183 (58.3)
|
63 (60.0)
|
|
Headache
|
166 (52.9)
|
46 (43.8)
|
|
Dizziness
|
123 (39.2)
|
37 (35.2)
|
|
Anorexia
|
108 (34.4)
|
37 (35.2)
|
|
Asthenia
|
108 (34.4)
|
33 (31.4)
|
|
Arthralgia
|
99 (31.5)
|
31 (29.5)
|
|
Nausea
|
82 (26.1)
|
34 (32.4)
|
|
Myalgia
|
74 (23.6)
|
19 (18.1)
|
|
Sleep disorder
|
70 (22.3)
|
30 (28.6)
|
|
Chills
|
67 (21.3)
|
20 (19.0)
|
|
Vomiting
|
50 (15.9)
|
22 (21.0)
|
|
Abdominal pain
|
61 (19.4)
|
20 (19.0)
|
|
Palpitation
|
55 (17.5)
|
17 (16.2)
|
|
Hepatomegaly
|
48 (15.3)
|
8 (7.6)
|
|
Splenomegaly
|
40 (12.7)
|
12 (11.4)
|
|
Fatigue
|
34 (10.8)
|
8 (7.6)
|
- AL: artemether/lumefantrine; MAS: mefloquine/artesunate
